Skip to main content
. 2022 Apr 14;26:101521. doi: 10.1016/j.ajoc.2022.101521

Fig. 3.

Fig. 3

Color fundus photograph and fluorescein/indocyanine green angiography (FA/IA) images of the right eye acquired 79 days after brolucizumab intravitreal injection. (A) Montage color fundus image showing drusen and sheathed retinal arteries. (B) Late phase (11 minutes) FA/IA images. FA (left) demonstrated filling defects (arrows) without vascular leakage or staining. IA (right) showed no dye staining on retinal vessels.